Introduction to BIRAC SBIRI Phase I
The Small Business Innovation Research Initiative (SBIRI) represents India's pioneer public-private partnership scheme in biotechnology, operated by BIRAC under the Department of Biotechnology (DBT), Government of India. Formulated to cultivate an innovation-driven culture among small and medium enterprises, SBIRI Phase I provides non-dilutive grant-in-aid of up to ₹50 Lakhs—covering up to 50% to 80% of project costs—to early-stage biotech startups and MSMEs for establishing proof-of-concept and validating novel technological feasibility.
Navigating the application process successfully requires strict adherence to eligibility parameters and a robust document checklist. This comprehensive guide walks you through everything you need to know about preparing your application, meeting compliance mandates, and leveraging this non-dilutive capital.
Scheme Overview & Objective
SBIRI Phase I is specifically engineered to de-risk high-potential biological hypotheses and transform them into tangible, validated lab prototypes. The scheme covers diverse life science verticals including:
- Point-of-care medical devices and diagnostic test kits
- Biopharmaceuticals and therapeutic molecules
- Agricultural bio-inputs and bio-fuels
- Industrial enzymes and environmental remediation technologies
By providing crucial early-stage non-dilutive funding, the scheme acts as a springboard to subsequent commercial scale-up phases, enabling entrepreneurs to focus on rigorous scientific validation without worrying about immediate equity dilution.
Eligibility Criteria & Scope
Before initiating your application, ensure your enterprise meets the strict eligibility criteria established by the Department of Biotechnology:
- Entity Type: Indian registered biotech companies (Private Limited, Public Limited, or LLP) equipped with in-house R&D facilities.
- Shareholding: At least 51% of equity shareholding must be owned by Indian resident citizens.
- Enterprise Scale: The entity must have fewer than 500 employees, strictly fitting the Small & Medium Enterprise definition.
- Matching Co-Funding: The applicant must be willing to contribute the required matching promoter co-funding share.
- Innovation Depth: The proposed innovation must be genuinely novel and address a significant commercial or healthcare challenge.
- Startup Relaxations: Startups under 5 years of incorporation receive relaxed eligibility requirements to encourage fresh entrepreneurial talent.
Key Financial & Growth Benefits
Securing the BIRAC SBIRI Phase I grant unlocks several strategic advantages for growing biotech enterprises:
- Up to ₹50 Lakhs Grant: Direct non-dilutive capital distributed across 3 to 4 structured milestone achievements.
- Zero Equity Dilution: Founding promoters preserve 100% intellectual property ownership and full strategic control.
- De-Risked Research: Funding covers raw materials, laboratory testing, cell lines, analytical assays, and pilot validation.
- Academia Collaboration: Formal integration allows collaboration with premier university research laboratories with dedicated sub-budgets.
- Expert Mentoring: Regular technical review and guidance from domain-specialist Project Monitoring Committees.
- Direct Gateway to Phase II: Successful Phase I validation grants direct eligibility for multi-crore SBIRI Phase II commercial scale-up funding.
To evaluate your business readiness for this scheme, explore our detailed resource portal at BIRAC SBIRI Phase I.
Application Procedure & Required Documents
Submitting a flawless application requires gathering all statutory and technical records beforehand. Below is the comprehensive document checklist mandated by BIRAC:
- Certificate of Incorporation, Memorandum of Association (MoA), Articles of Association (AoA), and a CA-certified Indian Shareholding Certificate.
- DPIIT Recognition Certificate (for startups) or DSIR R&D Recognition (for established firms).
- Detailed SBIRI Phase I Proposal outlining preliminary data, experimental protocol, and a milestone-based roadmap.
- Itemized Budget Breakdown complete with quotations for consumables, reagents, and equipment.
- Audited Financial Statements for the past two financial years (or a CA Net Worth Certificate for newly incorporated entities).
- Statutory Clearances such as Institutional Biosafety Committee (IBSC) or Institutional Animal Ethics Committee (IAEC) approvals if handling biological or animal samples.
- Company Bank Account Details alongside a cancelled cheque.
Step-by-Step Application Process
Preparing and submitting your proposal through the digital portal requires a structured methodology:
- Step 1: Registration: Register your company profile on the official BIRAC user portal using valid corporate credentials.
- Step 2: Proposal Drafting: Upload your technical proposal detailing the proof-of-concept objectives, methodology, and expected deliverables.
- Step 3: Budget Submissions: Attach itemized financial projections and milestone breakdowns corresponding to the 12 to 18-month project duration.
- Step 4: Compliance Uploads: Submit all mandatory statutory documents, including IBSC clearances and incorporation certificates.
- Step 5: Expert Review: Defend your proposal before the Project Monitoring Committee during technical evaluation rounds.
Official FAQs
1. What is the maximum grant amount provided under BIRAC SBIRI Phase I?
The scheme provides non-dilutive grant-in-aid of up to ₹50 Lakhs, covering between 50% to 80% of the total project cost.
2. What is the typical project duration for Phase I grants?
The proof-of-concept milestone tenure typically ranges between 12 to 18 months.
3. Do I need to dilute my company equity to secure this grant?
No. The SBIRI Phase I grant is non-dilutive, meaning your company retains 100% intellectual property ownership and equity distribution.
4. Can academic institutions collaborate on the project?
Yes, formal collaboration with premier university research laboratories is permitted, supported by dedicated sub-budgets within the project framework.
5. Where can I find more details on submitting my application?
You can review complete scheme details and guidelines directly at BIRAC SBIRI Phase I.
